Eliot M. Lurier

Chief Financial Officer, INTERLEUKIN GENETICS INC.

Companies

Marker Therapeutics, Inc.Chief financial officer Jul 5, 2023 to Jul 5, 2023¹
SomaLogic, Inc.Chief financial officer Jun 15, 2023 to Jun 15, 2023²
MUSTANG BIO, INC.Chief financial officer Jun 7, 2022 to Jun 7, 2022³
TENAX THERAPEUTICS, INC.Chief financial officer Nov 4, 2021 to Nov 4, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

TENAX THERAPEUTICS, INC. TENX0 shares⁵Nov 4, 2021
MUSTANG BIO, INC. MBIO0 shares⁶Jun 7, 2022

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMarker Therapeutics, Inc., Chief financial officer
2
SEC EDGARSomaLogic, Inc., Chief financial officer
3
SEC EDGARMUSTANG BIO, INC., Chief financial officer
4
SEC EDGARTENAX THERAPEUTICS, INC., Chief financial officer
5
SEC EDGARTENAX THERAPEUTICS, INC. shares after the filing of Nov 4, 2021
6
SEC EDGARMUSTANG BIO, INC. shares after the filing of Jun 7, 2022